You are here: Industry Insights > therapy

News List

COPD Treatment Landscape David Orchard-Webb
January 19, 2024
The comprehensive management of Chronic Obstructive Pulmonary Disease (COPD) requires a multi-faceted approach encompassing medications, lifestyle adjustments, and surgical interventions.
What are the new developments of the CNS drug R&D? ChatGPT/PharmaSources
November 08, 2023
The research and development of Central Nervous System (CNS) drugs have been the focus of ongoing advancements and innovations.
Pharmaceutical News of the Week (July. 6th-July. 10th) PharmaSources.com - Updates on Policies,Transactions and Others PharmaSources/Caicai
July 21, 2020
With the second week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 6 sections: approval, R&D, policies, transactions, listing and miscellany that happened during July 6-10.
PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC prnasia
August 04, 2020
PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to evaluate the combination of each party's clinical candidate, olinvacimab and C-005, a 3rd generation of EGFR inhibitor with superior b
FDA launches new programme to speed-up Covid-19 therapies pharmaceutical-technology
April 02, 2020
The US Food and Drug Administration (FDA) has launched a new programme aimed at accelerating the development of potential treatments for Covid-19 infection.
Testosterone Supplements Won't Help Most Men, Doctors' Group Says drugs
January 07, 2020
Testosterone therapy is no fountain of youth for older men, though it might help some who are impotent.That's according to new guidelines from the American College of Physicians -- the first from the group to address the issue of treating age-related "low
China's first self-developed carbon-ion therapy system gets market access NMPA
October 16, 2019
China's first self-developed carbon-ion therapy system has been approved by the national drug regulator and obtained market access.
US researchers develop CAR T cell therapy for cancer pharmaceutical-technology
September 27, 2019
Researchers at the City of Hope cancer research centre are developing a chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed blood cancers.
BioMarin Submits CTA in UK for Investigational Gene Therapy for PKU americanpharmaceuticalreview
September 27, 2019
BioMarin Pharmaceutical has submitted a Clinical Trial Application (CTA) with the Medicines and Healthcare Products Regulatory Agency (MHRA) in the U.K. for BMN 307 ...
Cryoport's New Shipper for Advanced Therapies contractpharma
September 26, 2019
Cryoport has launched its Advanced Therapy Shipper product line for the regenerative medicine market. The Advanced Therapy Shipper guarantees each shipper has been used only for human use and ...

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page